Last Posted: Oct 16, 2019
- Illuminating HIV outbreaks with AMD
CDC, October 2019 - Four Weeks of Treatment With Rifaximin Fails to Significantly Alter Microbial Diversity in Rectal Samples of HIV-Infected Immune Non-Responders (ACTG A5286) Which May be Attributed to Rectal Swab Use.
Williams Brett B et al. Pathogens & immunity 2019 (2) 235-250 - Longitudinal antibody responses in people who inject drugs infected with similar HIV strains.
Redd Andrew D et al. The Journal of infectious diseases 2019 Oct - New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017.
Wirden Marc et al. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2019 Sep (39) - Precision public health and HIV in Africa.
Blower Sally et al. The Lancet. Infectious diseases 2019 Oct 19(10) 1050-1052 - Low prevalence of transmitted HIV-1 drug resistance detected by a dried blood spot (DBS)-based next-generation sequencing (NGS) method in newly diagnosed individuals in Cameroon in the years 2015-16.
Mbunkah Herbert A et al. The Journal of antimicrobial chemotherapy 2018 07 (7) 1917-1929 - Single-Cell RNA-Seq Reveals Transcriptional Heterogeneity in Latent and Reactivated HIV-Infected Cells.
Golumbeanu Monica et al. Cell reports 2018 04 (4) 942-950 - A scale-free analysis of the HIV-1 genome demonstrates multiple conserved regions of structural and functional importance.
Skittrall Jordan P et al. PLoS computational biology 2019 Sep (9) e1007345 - High frequency of drug resistance mutations in the HBV genome in ART-experienced HIV-coinfected patients in southwestern Nigeria.
Akanbi Olusola Anuoluwapo et al. Antiviral therapy 2019 Sep - Rapid Identification and Investigation of an HIV Risk Network Among People Who Inject Drugs -Miami, FL, 2018.
Tookes Hansel et al. AIDS and behavior 2019 Sep
.png)
No hay comentarios:
Publicar un comentario